Lextegrity’s Integrity Gateway Approvals & Disclosures and Compliance Monitoring applications were chosen in an ongoing DOJ and SEC FCPA investigation by a leading global biopharmaceutical company.
A leading global life sciences company sought to enhance compliance controls and processes amid an ongoing FCPA investigation. Lextegrity’s Integrity Gateway Approvals & Disclosures and Integrity Gateway Compliance Monitoring applications were implemented quickly without the need for data scientists and engineers globally and in multiple languages. Compliance analytics and automation enhancements were implemented to bolster third-party risk management as well as monitor sponsorships and donations and benefits to government officials and healthcare professionals.
This case study will address:
The high-risk areas this leading biopharmaceutical company needed to address